In Monday’s session, the share of one of the leaders in branded generics in India moved up by 11.5 percent on BSE to hit an intraday high at Rs. 1,227.35, after the company received final approval from the USFDA for Betamethasone Valerate Foam.  With a market cap of Rs. 21,935.5 crores, at 11:18 a.m., the … Continue reading Pharma stock jumps 11% after it receives USFDA approval for its new drug